Findings of the IMMUTACE Trial in Hepatocellular Carcinoma - Targeted Oncology
8/9/2022 12:00:00 AM2 years 8 months ago
by Arndt Vogel, MD
by Arndt Vogel, MD
Arndt Vogel, MD, discusses the study results of the IMMUTACE study in hepatocellular carcinoma.
Arndt Vogel, MD, the managing senior consultant and professor in the department of Gastroenterology, Hepatology, and Endocrinology, at the Hannover Medical School, discusses the study results of the … [+1792 chars]
full article...